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The dependence of retroviral replication on cell proliferation was described as early as 1958, although different classes of retroviruses are able
to infect non-dividing cells with different efficiencies. For example, the human immunodeficiency virus (HIV) and other lentiviruses infect most
non-dividing cells nearly as well as dividing cells, while the gammaretroviruses such as the murine leukemia virus (MLV) cannot infect non-
dividing cells, and other retroviruses have intermediate phenotypes. One exception to the ability of HIV to infect non-dividing cells involves
resting CD4+ T cells in vitro where there are multiple restrictions. However, recent data show that there is massive infection of non-activated
CD4+ T cell during acute infection which suggests that the situation is different in vivo. Finally, much work trying to explain the difference
between HIV and MLV in non-dividing cells has focused on describing the ability of HIV to enter the nucleus during interphase. However, we
suggest that events in the viral lifecycle other than nuclear import may be more important in determining the ability of a given retrovirus to infect
non-dividing cells.
D 2005 Elsevier Inc. All rights reserved.
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Temin and Rubin published a paper in Virology in 1958
(Temin and Rubin, 1958) describing an in vitro assay to
quantitatively measure titers of Rous sarcoma virus (RSV), and
concluded that the physiological state of cells affects their
susceptibility to infection. The following year, the same authors
published another paper in Virology (Rubin and Temin, 1959)
showing that productive infection of RSV requires host cell
division since X-rays and UV light which inhibited cell growth
also prevented RSV production if cells were treated before, but
not after, infection. While the most prescient speculation in that0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.09.012
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E-mail address: memerman@fhcrc.org (M. Emerman).paper centered on the parallels between retroviruses and
lysogenic phage which later became the DNA provirus
hypothesis and garnered Howard Temin part of the Nobel Prize
(Temin, 1976), those early Virology papers also introduced the
concept that some aspect of cell cycle progression is an integral
part of the retroviral lifecycle. Research during the last half
century has provided some answers regarding the underlying
relationship between the cell cycle status of target cells and
retroviral replication, although many questions remain. This
relationship has important implications not only for the basic
biology of retroviruses, but also for our understanding of viral
pathogenesis. For example, it is the ability of the human
immunodeficiency virus (HIV) to infect non-cycling cells that
allows HIV replication in major viral reservoirs such as non-
activated CD4+ T cells and terminally differentiated macro-06) 88 – 93
www.e
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proliferation in retrovirus replication and highlight some of the
major questions in the field.
Different requirements for cell cycle progression between
different retroviruses
The relationship between infectivity and cell cycle stage
depends on the class of retrovirus (Katz et al., 2005).
Gammaretroviruses such as the murine leukemia virus (MLV)
and spleen necrosis virus (SNV) require mitosis for productive
infection and are blocked from integrating into non-dividing
cells (Caron and Caruso, 2005; Lewis and Emerman, 1994; Roe
et al., 1993). Alpharetroviruses, such as avian sarcoma virus
(ASV), differ from gammaretroviruses in that they integrate into
non-dividing cells (Hatziioannou and Goff, 2001; Katz et al.,
2002), but apparently require cell cycle progression for a step
later in the viral lifecycle (Humphries et al., 1981; Humphries
and Temin, 1974). Spumaviruses, a distinct group of retro-
viruses, also require cell cycle progression of their target cells
for successful replication (Bieniasz et al., 1995; Patton et al.,
2005; Trobridge and Russell, 2004). These cell cycle depen-
dencies are not absolute, however, and many of these retro-
viruses infect non-dividing cells at reduced efficiencies.
Specifically, gammaretroviruses have the poorest ability to
infect non-dividing cells (less than 1% as well as dividing cells),
alpharetroviruses transduce non-dividing cells 3–30% as well
as dividing cells (Hatziioannou and Goff, 2001; Katz et al.,
2002), while lentiviruses such as HIV show almost no
difference between dividing and non-dividing cells (Lewis et
al., 1992). Thus, some retroviruses are nearly totally dependent
on cell cycle progression, others show an intermediate
phenotype, and lentiviruses have almost no dependence on cell
proliferation. Although the cell cycle dependence of many other
retroviruses has not been directly tested, it is probable that other
classes of retroviruses rely on cell cycle progression for
productive infection since some of them induce proliferation
of target cells before infection (Czarneski et al., 2003) or rely on
proliferation-dependent receptors (Manel et al., 2003).
Resting T cells and HIV infection
Generally, HIV can infect cells that are arrested in the cell
cycle. An exception, however, is that HIV cannot infect naive
quiescent CD4+ T cells or monocytes isolated from peripheral
blood that are in the G0 stage of the cell cycle. Likewise, other
retroviruses are also restricted in G0 resting cells (Fritsch and
Temin, 1977; Harel et al., 1981; Varmus et al., 1977). However,
HIVand other lentiviruses (as well as ASV; Greger et al., 2004)
are able to infect cells in G0 that are terminally differentiated
and post-mitotic. These observations indicate that withdrawal
from the cell cycle alone is not sufficient to make cells resistant
to HIV and that other factors are important.
Importantly, subtle differences in cell ‘‘activation’’ play a
significant role in the ability of cells to support HIV replication.
For example, resting CD4+ T cells can be infected with HIV
(or HIV-derived vectors) when treated with cytokines such asIL-2, IL-4, IL-7, or IL-15, even though such treatment induces
neither cell proliferation nor other markers of T cell activation
(Unutmaz et al., 1999). Similarly, complex interactions of
resting T cells with B cells and factors secreted by macro-
phages can also render the T cell infectable by HIV without
inducing cell activation (Swingler et al., 2003). However, while
neither proliferating nor ‘‘activated’’, cells treated with these
factors may be pushed out of G0 and into the G1b part of the
cell cycle; a state defined by increased RNA synthesis in the
absence of both DNA synthesis and activation markers
(Dardalhon et al., 2001; Ducrey et al., 2002). This hypothesis
is consistent with studies showing that resting T cells treated
with mitogens could be infected when they entered G1b (Korin
and Zack, 1998). In contrast, these cells remain refractory to
gammaretroviral infection unless they are fully activated. Thus,
there is some physiological state of cells rendering them
permissive to lentiviruses as they emerge from quiescence but
before they acquire markers of activation or begin proliferation.
There are likely multiple mechanisms to explain why fully
quiescent cells cannot be infected by HIV, while ‘‘partially
activated’’ ones can. Complete reverse transcription of the HIV
genome is very slow in resting CD4+ T cells infected in vitro
(Pierson et al., 2002; Spina et al., 1995; Swiggard et al., 2004).
Quiescent cells contain low dNTP levels which might explain
the slow kinetics of reverse transcription. However, addition of
excess dNTPs to cells increases the amount of reverse
transcriptase products, but does not overcome the block to
infection (Korin and Zack, 1999). Thus, low dNTP pools in
quiescent cells do not fully explain the phenotype. Interesting-
ly, lentiviral reverse transcriptases have a higher binding
affinity to dNTPs than do gammaretroviral reverse transcrip-
tases (RT) (Operario et al., 2005; Skasko et al., 2005), and HIV
infection of cells where dNTP levels are low, such as non-
dividing macrophages, depends on an RT with a high Kd for
dNTPs (Diamond et al., 2004). These results imply that
lentiviruses evolved an enzyme to allow them to replicate in
environments where dNTP levels are low since cellular DNA
synthesis is absent.
Significantly, these data suggest that additional host cell
proteins or processes are necessary to mediate the completion of
HIV infection during the transition from quiescent cells to
‘‘partially activated’’ cells. Initially, it was suggested that a
transcriptional factor, NFAT, whose activation was thought to
enhance reverse transcription, might be a key regulator of HIV
infection of quiescent cells (Kinoshita et al., 1998). Subsequent
data, however, have shown that NFAT is not necessary for any of
the early steps of HIV replication (Ducrey et al., 2002; Oswald-
Richter et al., 2004). Instead, recent data have identified the
APOBEC3G protein as a factor that may actively inhibit HIV
infection in quiescent cells. APOBEC3G is a cytidine deaminase
that is inactivated by the HIV Vif protein in producer cells. More
recently, it has been suggested that this protein might play an
additional role in inhibition of HIV replication as part of a low-
molecular-mass (LMM) ribonucleoprotein complex in resting T
cells that blocks HIV infections by impairing the formation of
late products of reverse transcription via the RNA binding ability
of APOBEC3G (Chiu et al., 2005). However, at this point, the
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of APOBEC3G in resting cells is still correlative rather than
causal.
Even if reverse transcription is completed, there are
additional blocks both before and after integration of the HIV
genome in quiescent cells. For instance, lack of nuclear viral
DNA (Bukrinsky et al., 1992) suggests that nuclear import of
viral genomes is also inefficient in resting CD4+ T cells (but see
Wu and Marsh, 2001). There is also one report that claims that
cellular extracts from activated, but not resting CD4+ T cells,
support uncoating of HIV cores in vitro (Auewarakul et al.,
2005). Moreover, there are post-integration blocks to viral
expression that may lead to viral latency (reviewed in more
detail in Lassen et al., 2004; Williams and Greene, 2005). Thus,
there appears to be multiple blocks to HIV infection of resting T
cells in culture involving numerous host cell pathways.
HIV infection in vivo may be different from the in vitro models
Despite much work characterizing defects in HIV infection
of resting T cells isolated from peripheral blood, the situation in
whole tissues is quite different. In fact, naive CD4+ T cells in
human lymphoid tissue ex vivo can be productively infected
with HIVeven though they have not progressed to the G1b stage
of the cell cycle (Eckstein et al., 2001; Kinter et al., 2003).
Moreover, in situ hybridization for viral RNA has shown that
there is productive infection in non-activated cells in vivo
(Zhang et al., 1999). The importance of this observations for
lentiviral pathogenesis has become more clear with recent
publications that show massive infection of non-proliferating
memory T cells after acute infection with simian immunodefi-
ciency viruses (SIV) (Li et al., 2005; Mattapallil et al., 2005).
Many of the mucosal memory cells have gone through a recent
activation stage, and hence differ from the resting T cells in
periphery (Picker et al., 2004). However, even naive unac-
tivated resting CD4+ T cells in the periphery are productively
infected in animals infected with a particular highly pathogenic
simian–human immunodeficiency virus (SHIV) (Nishimura et
al., 2005). Thus, the microenviroments in vivo render resting
cells quite permissive to infection by lentiviruses. The
molecular basis for the difference between the facile infection
of resting T cells in vivo (and in tissues ex vivo) and the
refractory nature of resting T cells in isolation awaits further
description. However, the differences between the in vitro and
the in vivo results suggest that studies of blocks to HIV infection
in resting CD4+ T cells in isolation may not reflect the true
selective pressures that have affected lentivirus evolution.
Nuclear import or uncoating?
The complex of viral and cellular proteins that are
competent for integration of the viral genome is called the
pre-integration complex or PIC. Nuclear import of viral DNA
as part of the PIC is an essential step for the retrovirus life cycle
to carry out integration of the viral genome into the host cell
chromosome. Early studies on the block to infection in non-
dividing cells by MLV showed that mitosis was essential andsuggested that entry into the nucleus was the rate-limiting step
(Lewis and Emerman, 1994; Roe et al., 1993). It was proposed
that the viral DNA of gammaretroviruses gains access to the
host chromosome only when the nuclear membrane breaks
down at mitosis. Since HIV can access the nucleus before
mitosis, it has been assumed that the PIC of HIV contains
proteins with nuclear localization signals (NLS) that are
essential for the ability of HIV to infect non-dividing cells
(Bukrinsky et al., 1992). Several viral elements of lentiviruses
have been identified as potential components that contain an
NLS and have been postulated as being important for the
ability of lentiviruses to infect non-dividing cells. These
include the matrix (MA), integrase (IN), and Vpr proteins in
addition to a cis-acting element called central polypurine tract
(cPPT) (Bouyac-Bertoia et al., 2001; Bukrinsky et al., 1993a;
Gallay et al., 1995a, 1995b, 1997; Heinzinger et al., 1994; von
Schwedler et al., 1994; Zennou et al., 2000).
However, these results are controversial since HIV with
mutations in each of the identified NLSs still remains infectious
in non-dividing cells (Dvorin et al., 2002; Fouchier et al., 1997;
Freed et al., 1997; Limon et al., 2002a, 2002b; Petit et al.,
2000; Reil et al., 1998). Moreover, the presence of an NLS on
the PIC is not sufficient for infection of non-dividing cells
since addition of nuclear localization signals to gammaretro-
viruses does not increase their ability to infect non-dividing
cells (Caron and Caruso, 2005; Deminie and Emerman, 1994;
Seamon et al., 2002), and foamy virus, a retrovirus that
naturally encodes at least three proteins in its core with NLSs
(Imrich et al., 2000), is still not able to infect non-dividing cells
(Trobridge and Russell, 2004). Other studies have focused on
cellular proteins that may modulate the nuclear localization of
the HIV PIC such as the host protein called LEDGF which
directly binds to IN of HIV and feline immunodeficiency virus
(FIV), but not MLV, and can modulate the nuclear versus
cytoplasmic localization of IN (Llano et al., 2004; Maertens et
al., 2003). However, the significance of LEDGF as a mediator
of nuclear localization of the PIC is questionable since knock-
down of LEDGF by siRNA could prevent nuclear localization
of IN, but did not reduce the ability of HIV or FIV to infect
non-dividing cells (Llano et al., 2004).
There are two general explanations to account for the fact
that none of the described NLSs in the HIV PIC seems to be
essential for infection of non-dividing cells. First, it is possible
that lentiviruses have evolved to gain access to the nucleus
quickly such that each of the NLSs is redundant and they can
substitute for one another. However, we have recently deleted
all four of the described NLSs in the HIV PIC and still find that
the virus is able to infect non-dividing cells (Yamashita and
Emerman, 2005). It is possible, however, that there is still
another NLS that has yet to be described.
The second explanation is that nuclear import is not the
rate-limiting step for infection of non-dividing cells and the
focus on nuclear import has been misplaced. In support of this
second idea, we recently reported that the capsid protein (CA)
is a dominant determinant of retroviral infectivity in non-
dividing cells (Yamashita and Emerman, 2004) although CA is
not nucleophilic. The association of CA with incoming virions
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associated with intracellular complexes of MLV (Bowerman et
al., 1989; Fassati and Goff, 1999), but not HIV (Bukrinsky et
al., 1993b; Karageorgos et al., 1993; Khiytani and Dimmock,
2002; Miller et al., 1997). Thus, one hypothesis for the
dominant effect of CA on the ability of retroviruses to infect
non-dividing cells (Yamashita and Emerman, 2004) is that CA
affects the uncoating process due to its differential association
with intracellular viral complexes of MLV versus HIV. If
incoming virions can enter the nucleus only after uncoating
has proceeded, then uncoating, rather than nuclear import
might be the rate-limiting step in the ability to infect non-
dividing cells.
While CA is not associated with isolated HIV pre-
integration complexes, we know that it must be associated
with the entering virion at least initially because a large fraction
of intracellular incoming virions can be stained with a capsid
antibody (McDonald et al., 2002). In addition, HIV CA is the
target of a cytoplasmic antiviral protein called Trim5a (Lee and
KewalRamani, 2004) highlighting the fact that incoming HIV
virions maintain an association with CA for at least a short time
and must undergo a separate uncoating process. Thus, we
speculate that the interaction of CA with cytoplasmic factors
may ultimately govern the ability of different retroviruses to
infect non-dividing cells via regulation of the uncoating step.
Nuclear import may then be mediated by the association of
cellular factors with the PIC, but uncoating and cell cycle stage
may determine when or how these factors are able to mediate
that import. It is also possible that a downstream event such as
integration can be limiting for gammaretroviruses in non-
dividing cells.
Some of the confusion about nuclear import and retroviral
infection of non-dividing cells is caused by the experimental
systems used to monitor nuclear entry. For instance, the
reduction of LTR-circles, dead-end products of viral DNA, has
been widely used as evidence for a reduction in nuclear entry
of viral DNA. However, there are retroviral mutants that enter
the nucleus, but fail to produce LTR circles (Mannioui et al.,
2005; Yuan et al., 2002). Moreover, a recent report challenged
the assumption that 2-LTR circles are only found in the
nucleus (Serhan et al., 2004). It may be that 2-LTR circles are
better markers for the completion of reverse transcription than
for nuclear import, but in any case, it is not technically correct
to state that the absence of LTR circles always indicates a
failure of nuclear migration of viral DNA. Thus, future studies
to address the processes governing the access of retroviruses
to the nucleus in dividing and non-dividing cells will likely
require quantitative biochemical fractionations or real-time
imaging techniques. Additionally, novel uncoating assays
(Forshey et al., 2002; Narayan and Young, 2004) must be
considered to address the events that may precede nuclear
import.
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